Development of a Real-time Controller to Estimate Walking Performance Using a Bilateral Ankle Exoskeleton
Controller Development to Enable Individualized Assistance in Robotic Ankle Exoskeletons
2 other identifiers
interventional
6
1 country
1
Brief Summary
This study is developing and testing a new controller for a robotic ankle exoskeleton (Biomotum) that can adjust itself in real time to better support people while they walk. The system learns how each person moves and automatically changes the amount and timing of assistance to make walking feel easier and more efficient. By using information from the person wearing the device, the exoskeleton can quickly find the level of support that works best for them. The long-term goal is to create personalized walking assistance that can help people with mobility limitations move more comfortably and with less effort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2025
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
February 6, 2026
December 1, 2025
6 months
December 5, 2025
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Successful Real-Time Operation of the Robotic Ankle Exoskeleton Controller
Device feasibility will be evaluated by the successful real-time operation of the robotic ankle exoskeleton and adaptive controller during treadmill walking. Feasibility is defined as the controller's ability to continuously generate, update, and apply assistive torque in real time based on incoming biomechanical and physiological data without system failure, interruption, or safety-related termination. Successful operation will be confirmed by continuous controller function and synchronized data acquisition across walking trials.
through study completion, an average of 1 year
Secondary Outcomes (5)
Net Metabolic Rate During Exoskeleton-Assisted Walking Measured by Indirect Calorimetry
through study completion, an average of 1 year
Estimated Metabolic Rate Derived From Joint-Space Musculoskeletal Modeling
through study completion, an average of 1 year
Estimated Lower-Limb Muscle Activation Derived From Joint-Space Musculoskeletal Modeling
through study completion, an average of 1 year
Lower-Limb Muscle Activation Measured by Surface Electromyography During Walking
through study completion, an average of 1 year
During treadmill walking trials conducted at a single study visit
through study completion, an average of 1 year
Study Arms (1)
Single-Arm Study of a Personalized Robotic Ankle Exoskeleton Controller
EXPERIMENTALThis arm employs a within-subject design with two methods of estimating metabolic cost versus the gold standard measure of metabolic cost, wherein a single participant is subjected to two distinct measurements. This design allows for a direct comparison of the effects of each method (i.e., estimation versus gold standard) within the same individual, minimizing intersubject variability and enhancing the statistical power of the analysis.
Interventions
This intervention uses a robotic ankle exoskeleton equipped with a real-time adaptive controller that adjusts plantarflexion torque based on each participant's walking mechanics. Unlike standard exoskeleton controllers that use fixed or pre-programmed assistance levels, this system employs human-in-the-loop optimization to continuously update torque magnitude and timing during treadmill walking. The controller integrates metabolic estimations, kinematic data, and musculoskeletal modeling to identify individualized assistance patterns that reduce walking effort and improve muscle activation efficiency. Participants complete multiple walking trials while the controller automatically modifies assistance to determine the optimal personalized settings.
Eligibility Criteria
You may qualify if:
- able to walk independently on a treadmill for 10 minutes,
- free of neurological, cardiovascular, pulmonary, or musculoskeletal conditions that limit walking and exercising,
- no current lower extremity pain or injury,
- able to wear an exoskeleton and safety harness, can provide informed consent
You may not qualify if:
- history of neurological disease that affected gait or balance,
- current or recent lower extremity musculoskeletal injury or surgery,
- chronic lower extremity pain during walking,
- inability to participate in moderate-intensity exercise,
- require an assistive device for walking,
- any metabolic or systemic diseases that may be exacerbated by exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nebraskalead
- Madonna Rehabilitation Hospitalcollaborator
Study Sites (1)
Biomechanics Research Building, University of Nebraska at Omaha
Omaha, Nebraska, 68108, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Farah Fallahtafti, PhD
Department of Biomechanics, University of Nebraska at Omaha
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2025
First Posted
February 6, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
February 6, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared because direct measurements are only taken for baseline measurements that the modeling software will be using. The scripts and code used will be shared through opensource, but that does not include subject data.